Suppr超能文献

HIV-1整合酶核心结构域的三种新结构:一个结合镁的活性位点。

Three new structures of the core domain of HIV-1 integrase: an active site that binds magnesium.

作者信息

Goldgur Y, Dyda F, Hickman A B, Jenkins T M, Craigie R, Davies D R

机构信息

Laboratory of Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9150-4. doi: 10.1073/pnas.95.16.9150.

Abstract

HIV-1 integrase is an essential enzyme in the life cycle of the virus, responsible for catalyzing the insertion of the viral genome into the host cell chromosome; it provides an attractive target for antiviral drug design. The previously reported crystal structure of the HIV-1 integrase core domain revealed that this domain belongs to the superfamily of polynucleotidyltransferases. However, the position of the conserved catalytic carboxylic acids differed from those observed in other enzymes of the class, and attempts to crystallize in the presence of the cofactor, Mg2+, were unsuccessful. We report here three additional crystal structures of the core domain of HIV-1 integrase mutants, crystallized in the presence and absence of cacodylate, as well as complexed with Mg2+. These three crystal forms, containing between them seven independent core domain structures, demonstrate the unambiguous extension of the previously disordered helix alpha4 toward the amino terminus from residue M154 and show that the catalytic E152 points in the general direction of the two catalytic aspartates, D64 and D116. In the vicinity of the active site, the structure of the protein in the absence of cacodylate exhibits significant deviations from the previously reported structures. These differences can be attributed to the modification of C65 and C130 by cacodylate, which was an essential component of the original crystallization mixture. We also demonstrate that in the absence of cacodylate this protein will bind to Mg2+, and could provide a satisfactory platform for binding of inhibitors.

摘要

HIV-1整合酶是病毒生命周期中的一种必需酶,负责催化病毒基因组插入宿主细胞染色体;它为抗病毒药物设计提供了一个有吸引力的靶点。先前报道的HIV-1整合酶核心结构域的晶体结构表明,该结构域属于多核苷酸转移酶超家族。然而,保守催化羧酸的位置与该类其他酶中观察到的不同,并且在辅因子Mg2+存在下结晶的尝试未成功。我们在此报告HIV-1整合酶突变体核心结构域的另外三种晶体结构,它们在有无二甲胂酸盐的情况下结晶,以及与Mg2+复合的情况。这三种晶体形式总共包含七个独立的核心结构域结构,证明了先前无序的α4螺旋从残基M154向氨基末端明确延伸,并表明催化性的E152指向两个催化性天冬氨酸D64和D116的大致方向。在活性位点附近,无二甲胂酸盐时蛋白质的结构与先前报道的结构有显著偏差。这些差异可归因于二甲胂酸盐对C65和C130的修饰,二甲胂酸盐是原始结晶混合物的重要成分。我们还证明,在没有二甲胂酸盐的情况下,这种蛋白质会与Mg2+结合,并可为抑制剂的结合提供一个合适的平台。

相似文献

6
HIV-1 integrase: the next target for AIDS therapy?HIV-1整合酶:艾滋病治疗的下一个靶点?
Pathol Biol (Paris). 2001 Apr;49(3):237-46. doi: 10.1016/s0369-8114(01)00135-3.
8
Similarities in the HIV-1 and ASV integrase active sites upon metal cofactor binding.金属辅因子结合后HIV-1和ASV整合酶活性位点的相似性。
Biopolymers. 2000 Apr 5;53(4):308-15. doi: 10.1002/(SICI)1097-0282(20000405)53:4<308::AID-BIP3>3.0.CO;2-H.

引用本文的文献

本文引用的文献

6
Retroviral integrase, putting the pieces together.逆转录病毒整合酶:整合过程解析
J Biol Chem. 1996 Aug 16;271(33):19633-6. doi: 10.1074/jbc.271.33.19633.
10
The human immunodeficiency virus integrase protein.人类免疫缺陷病毒整合酶蛋白。
Trends Genet. 1993 Dec;9(12):433-8. doi: 10.1016/0168-9525(93)90107-s.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验